Syros Pharmaceuticals Inc. (NASDAQ: SYRS) flaunted slowness of -11.97% at $13.16, as the Stock market unbolted on January 20, 2021. During the day, the stock rose to $15.25 and sunk to $12.85 before settling in for the price of $14.95 at the close. Taking a more long-term approach, SYRS posted a 52-week range of $4.26-$15.65.
Meanwhile, its Annual Earning per share during the time was -22.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 1.70%. This publicly-traded company’s shares outstanding now amounts to $45.78 million, simultaneously with a float of $42.78 million. The organization now has a market capitalization sitting at $591.41 million. At the time of writing, stock’s 50-day Moving Average stood at $10.37, while the 200-day Moving Average is $10.03.
It is quite necessary to find out the efficiency of the corporate organization, which has 83 number of employees on its payroll. It has generated 23,880 per worker during the last fiscal year. Meanwhile, its income per employee was -908,892. The stock had 0.20 Receivables turnover and 0.02 Total Asset turnover. For the Profitability, stocks operating margin was -3922.35 and Pretax Margin of -3806.16.
Syros Pharmaceuticals Inc. (SYRS) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Syros Pharmaceuticals Inc. industry. According to the most recent insider trade that took place on Nov 17, this organization’s Director sold 5,357 shares at the rate of 8.75, making the entire transaction reach 46,874 in total value, affecting insider ownership by 339,211. Preceding that transaction, on Nov 16, Company’s Director sold 633 for 8.98, making the whole transaction’s value amount to 5,684. This particular insider is now the holder of 344,568 in total.
Syros Pharmaceuticals Inc. (SYRS) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 9/29/2020, it has been observed that the corporation posted -$0.43 earnings per share (EPS) during the time that was less the consensus figure (set at -$0.38) by -$0.05. This company achieved a net margin of -3806.16 while generating a return on equity of -95.63. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
Syros Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 1.70% and is forecasted to reach -1.70 in the upcoming year.
Syros Pharmaceuticals Inc. (NASDAQ: SYRS) Trading Performance Indicators
Let’s observe the current performance indicators for Syros Pharmaceuticals Inc. (SYRS). It’s Quick Ratio in the last reported quarter now stands at 3.50. The Stock has managed to achieve an average true range (ATR) of 1.52. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 59.74.
In the same vein, SYRS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.65, a figure that is expected to reach -0.50 in the next quarter, and analysts are predicting that it will be -1.70 at the market close of one year from today.
Technical Analysis of Syros Pharmaceuticals Inc. (SYRS)
Now, what If we examine the latest scores posted by [Syros Pharmaceuticals Inc., SYRS]. During the last 5-days, its volume was better the volume of 0.96 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 75.56% While, its Average True Range was 1.53.
Raw Stochastic average of Syros Pharmaceuticals Inc. (SYRS) in the period of the previous 100 days is set at 73.08%, which indicates a major rise in contrast to 57.79% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 109.89% that was higher than 99.44% volatility it exhibited in the past 100-days period.